Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone pharmacokinetics after subcutaneous versus intramuscular administration in chronic adrenal insufficiency
2011-002687-25Phase 2Completed
- Sponsor
- University Hospital Würzburg
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hydrocortisone in Addison's disease (2 arms), sponsored by University Hospital Würzburg. Primary endpoints: Time to cortisol threshold required in critical illness, Proportion achieving cortisol threshold and 8 more. Started Oct 2011; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Addison's disease
Beyond the preview
Go deeper on 2011-002687-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002687-25.